Lincoln International Announces Managing Director Promotions 2022

Lincoln International, a global investment banking advisory firm, is pleased to announce the promotion of six Directors to Managing Director (MD), effective January 1, 2023.

“Each of these individuals contributes to their clients, teams and the firm in impactful ways – from industry expertise and advice to internal collaboration that creates unique and meaningful outcomes,” stated Rob Brown, Chief Executive Officer of Lincoln International. “We are thrilled to recognize their accomplishments and celebrate their achievements while looking forward to their continued leadership and stewardship in 2023.”

The new MDs join more than 150 globally who provide complementary investment banking advisory services in the private capital markets. Their mergers and acquisitions (M&A) and capital advisory acumen bolster the firm’s senior leadership in both expertise and commitment to outstanding outcomes.

Outlined below are further details about Lincoln’s newest MDs, in alphabetical order:

Tim Blonn | Chicago

Tim advises private equity groups and private companies on acquisitions, refinancings, recapitalizations and restructurings with a recognized expertise in healthcare. He utilizes more than 15 years of advisory, direct lending and capital markets experience to arrange tailored financing solutions, including senior and unitranche loans, subordinated debt and structured capital. Tim joined Lincoln in 2018 as a Vice President.

Jesse Espinoza | San Francisco

Jesse provides M&A advisory services for clients in the technology, media and telecom (TMT) sector, with more than 10 years of experience advising on sell-side and buy-side transactions, cross-border advisory and strategic alternatives for privately held businesses, leading private equity firms and publicly traded companies. He has deep expertise across the TMT sector, with comprehensive knowledge of enterprise software, engineering, design and simulation software and industrial technology broadly, among other subsectors. Jesse joined Lincoln in 2018 as a Vice President.

Sherman Guillema | Dallas

Sherman provides capital advisory services for a broad range of circumstances, including acquisition financing, recapitalizations, refinancing, restructurings, liability management transactions and distressed mergers and acquisitions drawing from more than 15 years of advisory and credit investing experience. Sherman’s clients include private equity groups, publicly held companies and family-owned businesses. Sherman joined Lincoln in 2015 as a Vice President.

Sam Jackson | New York

Sam provides M&A advisory services to clients in the TMT sector, with a focus on enterprise software and financial technology. His more than 12 years of experience includes transactions involving Fortune 500 and publicly traded companies as well as advising leading private equity firms and privately held businesses on strategic alternatives. Sam joined Lincoln in 2012 as an Associate.

Neil Maini | New York

Neil leverages his direct lending experience to arrange financings for private equity sponsors, independent sponsors and private companies in a variety of transactions including acquisitions, mergers, recapitalizations and refinancings. His expertise includes designing direct lending solutions to sponsors and private companies including first lien, unitranche, second lien and mezzanine financings. Neil joined Lincoln in 2020 as a Director.

James West | London

James provides M&A advisory services for clients in the pharmaceutical and life sciences sector. He has expert knowledge in outsourced pharmaceutical research, manufacturing and commercialization services, pharmaceutical products and medical technology and diagnostics. James has more than 10 years of experience working globally with private equity, public and private clients. James joined Lincoln in 2021 as a Director.


  • Bolsters the firm’s senior leadership in both expertise and commitment to outstanding outcome.


Meet Professionals with Complementary Expertise

Related Perspectives

PETS International | Consolidation Meets Regulation in the Veterinary Clinics Market

Originally posted by PETS International on April 5, 2024. Animal health is becoming a big business in Europe and the U.S. Thus, regulators are turning a closer eye to mergers… Read More

“Leader to Leader” Series

The Leader to Leader video series turns up the dial on rich conversations with prominent leaders – from business owners and entrepreneurs to investors and CEOs – highlighting their stories… Read More

What Price is Right? Trends and Opportunities for Private Equity in Pharma Market Access

The cost of developing new drugs is staggering. Among the top 20 global biopharmas, the average cost of developing a candidate from discovery through clinical trials to market was approximately… Read More

Investment Opportunities in Pharma: A Data-Driven Exploration of CDMO Appeal

The report discusses the current state of the contract development and manufacturing organization (CDMO) market within the pharmaceutical industry, emphasizing the increased interest from private equity (PE) investors. The pharmaceutical… Read More